Page last updated: 2024-08-21

physcione and Cancer of Cervix

physcione has been researched along with Cancer of Cervix in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Król, T; Stachurska, A; Trybus, E; Trybus, W	1
Guo, H; Sun, D; Xiang, Z; Zhang, Y	1

Other Studies

2 other study(ies) available for physcione and Cancer of Cervix

Article	Year
Physcion Induces Potential Anticancer Effects in Cervical Cancer Cells. Cells, 2021, 08-08, Volume: 10, Issue:8 Topics: Antineoplastic Agents; Apoptosis; Autophagy; Caspase 3; Cell Cycle; Cell Survival; Emodin; Female; HeLa Cells; Humans; Lysosomes; Membrane Potential, Mitochondrial; Microscopy, Electron, Transmission; Microscopy, Fluorescence; Mitochondria; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Uterine Cervical Neoplasms	2021
Inhibiting 6-phosphogluconate dehydrogenase enhances chemotherapy efficacy in cervical cancer via AMPK-independent inhibition of RhoA and Rac1. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2019, Volume: 21, Issue:4 Topics: AMP-Activated Protein Kinases; Animals; Apoptosis; Biomarkers, Tumor; Cell Movement; Cell Proliferation; Chemotherapy, Adjuvant; Emodin; Female; Gene Expression; Humans; Mice, SCID; Paclitaxel; Phosphogluconate Dehydrogenase; rac1 GTP-Binding Protein; rhoA GTP-Binding Protein; Tumor Cells, Cultured; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays	2019

Article

Year

Physcion Induces Potential Anticancer Effects in Cervical Cancer Cells.

Cells, 2021, 08-08, Volume: 10, Issue:8

Topics: Antineoplastic Agents; Apoptosis; Autophagy; Caspase 3; Cell Cycle; Cell Survival; Emodin; Female; HeLa Cells; Humans; Lysosomes; Membrane Potential, Mitochondrial; Microscopy, Electron, Transmission; Microscopy, Fluorescence; Mitochondria; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Uterine Cervical Neoplasms

2021

Inhibiting 6-phosphogluconate dehydrogenase enhances chemotherapy efficacy in cervical cancer via AMPK-independent inhibition of RhoA and Rac1.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2019, Volume: 21, Issue:4

Topics: AMP-Activated Protein Kinases; Animals; Apoptosis; Biomarkers, Tumor; Cell Movement; Cell Proliferation; Chemotherapy, Adjuvant; Emodin; Female; Gene Expression; Humans; Mice, SCID; Paclitaxel; Phosphogluconate Dehydrogenase; rac1 GTP-Binding Protein; rhoA GTP-Binding Protein; Tumor Cells, Cultured; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays

2019